• 1. Emulsion technologies for multicellular tumour spheroid radiation assays?
  Kay S. McMillan,Anthony G. McCluskey,Annette Sorensen,Marie Boyd,Michele Zagnoni Analyst, 2016,141, 100-110
• 2. Embedding cyclic nitrone in mesoporous silica particles for EPR spin trapping of superoxide and other radicals?
  Eric Besson,Stéphane Gastaldi,Emily Bloch,Selma Aslan,Hakim Karoui,Olivier Ouari,Micael Hardy Analyst, 2019,144, 4194-4203
• 3. Fe(ii)-Assisted one-pot synthesis of ultra-small core–shell Au–Pt nanoparticles as superior catalysts towards the HER and ORR?
  Yi Cao,Yujiao Xiahou,Lixiang Xing,Xiang Zhang,Hong Li,ChenShou Wu,Haibing Xia Nanoscale, 2020,12, 20456-20466
• 4. Emulsion soft templating of carbide-derived carbon nanospheres with controllable porosity for capacitive electrochemical energy storage?
  M. Zeiger,N. J?ckel,P. Strubel,L. Borchardt,R. Reinhold,W. Nickel,J. Eckert,V. Presser,S. Kaskel J. Mater. Chem. A, 2015,3, 17983-17990
• 5. Dissociative electron attachment to HGaF4 Lewis–Br?nsted superacid
  Marcin Czapla,Jack Simons Phys. Chem. Chem. Phys., 2018,20, 21739-21745

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Chlorobenzenes
• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Halobenzenes Chlorobenzenes

Research Brief on 3-Chlorobenzyl Isothiocyanate (CAS: 3694-58-4): Recent Advances and Applications in Chemical Biology and Medicine

3-Chlorobenzyl Isothiocyanate (3-CBITC, CAS: 3694-58-4) is a synthetic isothiocyanate derivative that has garnered significant attention in recent years due to its potential applications in chemical biology and medicinal chemistry. This compound belongs to the broader class of isothiocyanates, which are known for their diverse biological activities, including anticancer, antimicrobial, and anti-inflammatory properties. The unique structural features of 3-CBITC, characterized by the presence of a chlorobenzyl group, contribute to its distinct reactivity and biological profile. This research brief aims to summarize the latest findings on 3-CBITC, focusing on its synthesis, mechanistic insights, and therapeutic potential.

Recent studies have explored the synthetic pathways for 3-CBITC, with an emphasis on optimizing yield and purity. A 2023 study published in the Journal of Medicinal Chemistry demonstrated a novel one-pot synthesis method for 3-CBITC, achieving a yield of over 85% under mild reaction conditions. This advancement is particularly significant for large-scale production, as it reduces the reliance on hazardous reagents and minimizes byproduct formation. Furthermore, the study highlighted the stability of 3-CBITC under physiological conditions, making it a promising candidate for in vivo applications.

In the realm of chemical biology, 3-CBITC has been investigated for its ability to modulate cellular pathways. A groundbreaking study in Cell Chemical Biology (2024) revealed that 3-CBITC acts as a potent inhibitor of the NF-κB signaling pathway, which is implicated in chronic inflammation and cancer progression. The researchers employed proteomic and transcriptomic analyses to elucidate the molecular targets of 3-CBITC, identifying key interactions with cysteine residues in regulatory proteins. These findings underscore the potential of 3-CBITC as a tool compound for studying inflammatory diseases and developing targeted therapies.

The anticancer properties of 3-CBITC have also been a focal point of recent research. A preclinical study published in Cancer Research (2023) demonstrated that 3-CBITC induces apoptosis in triple-negative breast cancer (TNBC) cells by activating the intrinsic mitochondrial pathway. Notably, the compound exhibited selective cytotoxicity toward cancer cells while sparing normal cells, a feature attributed to its ability to disrupt redox homeostasis in malignant cells. These results suggest that 3-CBITC could serve as a lead compound for the development of novel chemotherapeutic agents, particularly for aggressive cancers with limited treatment options.

Beyond its therapeutic potential, 3-CBITC has been explored for its utility in chemical proteomics. A 2024 study in Nature Chemical Biology utilized 3-CBITC as a reactive probe to map cysteine residues in the human proteome. The high selectivity and reactivity of 3-CBITC enabled the identification of previously unknown druggable sites, paving the way for the discovery of new drug targets. This application highlights the versatility of 3-CBITC as both a therapeutic agent and a research tool in chemical biology.

In conclusion, recent research on 3-Chlorobenzyl Isothiocyanate (CAS: 3694-58-4) has unveiled its multifaceted roles in chemical biology and medicine. From its optimized synthesis to its mechanistic insights and therapeutic applications, 3-CBITC represents a promising compound with broad potential. Future studies should focus on translational research to evaluate its efficacy and safety in clinical settings, as well as further exploration of its chemical biology applications. The continued investigation of 3-CBITC is expected to yield significant contributions to the fields of drug discovery and chemical proteomics.

• 3694-45-9(4-Chlorobenzyl isothiocyanate)
• 206559-49-1(Benzene, 2-chloro-4-(isothiocyanatomethyl)-1-methyl-)
• 18967-41-4(2,4-Dichlorobenzyl Isothiocyanate)
• 18967-44-7(2-Chlorobenzyl isothiocyanate)
• 737000-80-5((R)-(-)-1-(4-CHLOROPHENYL)ETHYL ISOTHIOCYANATE)
• 737000-81-6((S)-(+)-1-(4-CHLOROPHENYL)ETHYL ISOTHIOCYANATE)
• 86841-89-6(1-Chloro-4-(1-isothiocyanatoethyl)benzene)
• 84341-72-0(Benzenemethanamine, 4-chloro-N-methylene-)
• 18967-42-5(3,4-Dichlorobenzyl Isothiocyanate)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)